Who knows....maybe ARQL will be the surprise "star" of ASCO. I dnt know about anyne else, but I think $400 million is undervalued. I think they did a good job raising money where they did, there was strong demand. Celldex certainly isn't acting all that bright anymore.
Market Data 
Markets 
AI
